Topic: Payment & Reimbursement

  • Medicare Part B Premium Dynamics Explained

  • Production Plus Profit Pricing (P-quad) FAQ

  • Medicare Must Study Unproven, Expensive Alzheimer’s Drug

  • Value-Based Management of Specialty Drugs: Practical Considerations and Implications for Pharmacy

  • CMS’s Proposed Medicaid Best Price Loophole for Value-Based Purchasing of Drugs

  • The Drugs at the Heart of Our Pricing Crisis

  • Who Is Sowing Seeds of Confusion About The QALY?

  • Pharmaceutical Products and Their Value: Lessons Learned and the Path Ahead

  • Dissecting PhRMA’s Opposition to H.R. 3 Lower Drug Costs Now Act of 2019

  • Mortgaging New Treatments Kicks the Can on High Drug Prices